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Abstract
Introduction: In acute respiratory distress syndrome (ARDS), combined high-frequency oscillation (HFO) and
tracheal gas insufflation (TGI) improves gas exchange compared with conventional mechanical ventilation (CMV).
We evaluated the effect of HFO-TGI on PaO2/fractional inspired O2 (FiO2) and PaCO2, systemic hemodynamics,
intracranial pressure (ICP), and cerebral perfusion pressure (CPP) in patients with traumatic brain injury (TBI) and
concurrent severe ARDS.
Methods: We studied 13 TBI/ARDS patients requiring anesthesia, hyperosmolar therapy, and ventilation with
moderate-to-high CMV-tidal volumes for ICP control. Patients had PaO2/FiO2 <100 mm Hg at end-expiratory
pressure ≥10 cm H2O. Patients received consecutive, daily, 12-hour rescue sessions of HFO-TGI interspersed with
12-hour periods of CMV. HFO-TGI was discontinued when the post-HFO-TGI PaO2/FiO2 exceeded 100 mm Hg for
>12 hours. Arterial/central-venous blood gases, hemodynamics, and ICP were recorded before, during (every 4
hours), and after HFO-TGI, and were analyzed by using repeated measures analysis of variance. Respiratory
mechanics were assessed before and after HFO-TGI.
Results: Each patient received three to four HFO-TGI sessions (total sessions, n = 43). Pre-HFO-TGI PaO2/FiO2 (mean
± standard deviation (SD): 83.2 ± 15.5 mm Hg) increased on average by approximately 130% to163% during HFO-
TGI (P < 0.01) and remained improved by approximately 73% after HFO-TGI (P < 0.01). Pre-HFO-TGI CMV plateau
pressure (30.4 ± 4.5 cm H2O) and respiratory compliance (37.8 ± 9.2 ml/cm H2O), respectively, improved on
average by approximately 7.5% and 20% after HFO-TGI (P < 0.01 for both). During HFO-TGI, systemic
hemodynamics remained unchanged. Transient improvements were observed after 4 hours of HFO-TGI versus pre-
HFO-TGI CMV in PaCO2 (37.7 ± 9.9 versus 41.2 ± 10.8 mm Hg; P < 0.01), ICP (17.2 ± 5.4 versus 19.7 ± 5.9 mm Hg; P
< 0.05), and CPP (77.2 ± 14.6 versus 71.9 ± 14.8 mm Hg; P < 0.05).
Conclusions: In TBI/ARDS patients, HFO-TGI may improve oxygenation and respiratory mechanics, without
adversely affecting PaCO2, hemodynamics, or ICP. These findings support the use of HFO-TGI as a rescue
ventilatory strategy in patients with severe TBI and imminent oxygenation failure due to severe ARDS.
Introduction
The management of patients with traumatic brain injury
(TBI) becomes challenging when complicated by acute
respiratory distress syndrome (ARDS) [1,2]. Hypoxemia,
hypercapnia, and hypotension are rather frequent in
ARDS, either as original clinical manifestations, or as con-
sequence(s) of the conventional mechanical ventilation
(CMV) strategy [3-5]. TBI ventilatory goals include ade-
quate oxygenation as well as CO2 elimination for the con-
trol of intracranial pressure (ICP) and cerebral perfusion
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pressure (CPP) [5,6]. However, the use of moderate-to-
high tidal volumes and high respiratory rates predisposes
TBI patients to ventilator-induced lung injury [4,5].
High-frequency oscillation (HFO) aims at optimizing
lung protection [7-10] and recruitment [11]. However,
data on the effects of HFO on PaCO2, hemodynamics,
and ICP in patients with TBI and ARDS are sparse and
originate from small, retrospective case series [12-14].
Increases in ICP secondary to transient increases in
PaCO2 have previously been reported during HFO
[12,13]. Hypercapnia occurs commonly during HFO,
even at relatively low HFO frequencies of ~5 Hz [15].
Conversely, the addition of tracheal gas insufflation
(TGI) to HFO enhances CO2 elimination [16,18], and
improves oxygenation [16-19]. In the present study, we
hypothesized that rescue sessions of HFO-TGI adminis-
tered to TBI patients with severe ARDS could result in
improved gas exchange, higher post-HFO-TGI respira-
tory compliance, and less-traumatic CMV pressures
[19], without adversely affecting ICP and/or CPP.
Materials and methods
The study was conducted between June 2009 and June
2012 in the mixed medical and surgical 30-bed intensive
care unit (ICU) of Evaggelismos Hospital, Athens, Greece.
Informed, written next-of-kin consent was obtained for all
participants. The study was approved by the Scientific
Council and the Ethics Committee of Evaggelismos
Hospital.
Patients
Eligible patients had early (that is, onset within ≤72 hours)
ARDS [19,20] with severe oxygenation disturbances
(defined as PaO2/fractional inspired O2 (FiO2) ≤ 100 mm
Hg at positive end-expiratory pressure (PEEP) ≥10 cm
H2O), and severe TBI (that is, preintubation Glasgow
Coma Score <8 [21]). Target ICP was ≤20 mm Hg; thus,
the threshold for increasing therapy-intensity level (TIL)
for ICP control was ICP > 20 mm Hg [5,6,22]. TIL
comprised a minimum of head elevation (20 degrees to
30 degrees relative to horizontal), higher-dose sedation/
neuromuscular blockade, hemodynamic support to main-
tain a target CPP of ≥60 mm Hg [5,6,22], hyperosmolar
therapy, and prevention of hyperthermia ([23]; see also
Additional file 1).
We applied previously published exclusion criteria ([19];
Additional file 1), in addition to ICP >30 mm Hg, and
brain death or imminent risk of brain herniation. Patient
monitoring included continuous display of electrocardio-
graphic lead II and peripheral oxygen saturation, intraar-
terial blood pressure, cardiac output/index (PICCO-plus;
Pulsion Medical Systems, Munich, Germany), core patient
temperature, and ICP (Codman ICP monitoring system;
Codman & Shurtleff, Raynham, MA, USA).
Study design
We conducted a prospective, interventional, noncontrolled
study on the physiological effects of intermittent, rescue
HFO-TGI in TBI/ARDS patients. In a recent randomized
controlled trial of severe ARDS [19], we showed that 6 or
more-hour HFO-TGI sessions (average daily HFO-TGI
use, 12.4 hours) with recruitment maneuvers (RMs) are
associated with significant improvements in oxygenation,
plateau pressure, and respiratory compliance during post-
session CMV versus presession CMV; HFO-TGI did not
significantly affect hemodynamics. Our rescue intervention
comprised daily, 12-hour sessions of HFO-TGI and RMs,
interspersed with 12-hour periods of CMV (Figure 1). The
rescue intervention was discontinued when a PaO2/FiO2
of >100 mm Hg could be maintained for >12 hours during
post-HFO-TGI CMV, with CMV-plateau airway pressure
of ≤35 cm H2O.
Study protocol
Baseline CMV period
Details are provided in Additional file 1. On enrolment,
patients were ventilated with attending physician-
prescribed volume assist-control CMV. CMV settings
were already titrated to the best possible combinations of
PaO2/FiO2 (target ≥100 mm Hg, with PaO2 maintained
>90 mm Hg [5,22]), PaCO2 (target 35 to 45 mm Hg),
plateau pressure (target, ≤35 cm H2O), and ICP/CPP. An
arterial blood gas analysis was performed, respiratory
mechanics were assessed with rapid end-inspiratory/end-
expiratory airway occlusion [16-19], and the Murray score
[24] was calculated.
Tracheal tube (inner diameter, 8.0 to 9.0 mm) correct
positioning and patency were verified, and a circuit
adapter/TGI-catheter system was inserted, as previously
described [16-19]; Additional file 1. Sixty minutes there-
after, we conducted the study’s baseline, physiologic CMV
measurements (arterial/central venous blood gas analysis,
hemodynamics and ICP, and respiratory mechanics) at
FiO2 = 1.0 (Figure 1).
HFO-TGI and RMs protocol
Patients were connected to the 3100B HFO ventilator
(Sensormedics; Yorba Linda, CA, USA), and after a 10-
to 20-second period of standard HFO ventilation, a
20-second RM was performed by pressurizing the HFO
breathing circuit at 40 to 45 cm H2O with the oscillator
piston off. RMs were administered only to patients with
ICP ≤25 mm Hg and CPP ≥60 mm Hg during pre-HFO-
TGI CMV. RM-abort criteria were ICP increase to >25
mm Hg or CPP decrease to <60 mm Hg during an RM;
whenever these criteria were met, RMs were suspended
until the HFO-TGI session of the next study day.
Initial HFO settings (Figure 1) were aimed at optimizing
lung recruitment and PaCO2 control. A tracheal tube cuff
leak and TGI were used as previously described (Figure 1
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[16-19]; Additional file 1). For study purposes, we docu-
mented physiological measurements (arterial/central
venous blood gas analysis, and hemodynamics/ICP) at 4,
8, and 12 hours after HFO initiation. The sequence of
RMs, oxygenation-based titrations in mean airway pres-
sure (mPaw), and PaCO2-based titrations of HFO fre-
quency and oscillatory pressure amplitude (ΔP) is
illustrated in Figure 1. If, at 12 hours, the PaO2/FiO2 was
still <100 mm Hg, the daily HFO-TGI session was to be
extended for at least 24 hours (that is, until the end of the
next day’s session [19]).
In the event that ICP would exceed the pre-HFO-TGI
value by 5 mm Hg, or reach 30 mm Hg in absolute value
for >15 minutes, the HFO-TGI session was to be inter-
rupted, with consequent return to pre-HFO-TGI CMV
and cancellation of any further HFO-TGI intervention.
During HFO-TGI, any RM-and/or HFO-TGI-associated
hypotension (defined as mean arterial pressure <70 mm
Hg) lasting for >1 minute was to be treated with norepi-
nephrine and/or a 300 to 500-ml bolus of crystalloid [19].
Post HFO-TGI CMV period
If, after 12 hours of HFO-TGI, PaO2/FiO2 exceeded 100
mm Hg, patients were returned to CMV with the pre-
HFO-TGI settings (including the FiO2 = 1.0) maintained
unchanged for 30 minutes. Subsequently, we performed
the post-HFO-TGI physiological measurements. Further-
more, within the next 12 hours, CMV ventilatory settings
and TIL for ICP control were retitrated as necessary, in
concordance with the previously described targets and
limits. Twelve hours after return to CMV, patients were
assessed for return to HFO-TGI, according to the pre-
viously described, oxygenation/plateau-pressure criterion.
Figure 1 Schematic representation of the study protocol. CMV, conventional mechanical ventilation; RM, recruitment maneuver; HFO, high-
frequency oscillation; TGI, tracheal gas insufflation; mPaw, mean airway pressure; f, oscillation frequency; ΔP, oscillatory pressure amplitude; minV,
minute ventilation; FiO2, fractional inspired oxygen. *Includes the (1) confirmation of correct positioning and patency of tracheal tubes by chest
radiography and 10-second or less fiberoptic endoscopy, respectively [19-21,23]; (2) introduction of a TGI catheter (through a dedicated circuit
adapter) and positioning of the TGI catheter tip at 0.5 to 1.0 cm beyond the tracheal tube tip, as previously described [[18-20,22]; Additional file
1]; and (3) minor ventilatory adjustments aimed at further, concurrent optimization of PaCO2, intracranial pressure, and plateau pressure
(Additional file 1). This patient preparation was carried out once, immediately after study enrolment. †Period duration was as illustrated on study
day 1; on a subsequent study day, it constituted a 60-minute pre-HFO-TGI CMV period that followed the 11-hour post-HFO-TGI CMV period of
the preceding study day. §Depending on tracheal tube inner diameter (9.0, 8.5, or 8.0 mm) [17], the HFO mPaw was set at 10, 12, or 15 cm H2O
(respectively) above preceding CMV mPaw [20]. ‡Performed by pressurizing the HFO breathing circuit at 40 to 45 cm H2O for 20 seconds with
oscillator piston off. **Causing a 3- to 5-cm H2O decrease in mPaw, which was reversed by adjusting the mPaw valve; the tracheal tube cuff leak
was placed immediately after the first RM. #PaCO2 of HFO-TGI was to be maintained within 30 to 50 mm Hg.
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The last 60 minutes of this CMV period corresponded to
the pre-HFO-TGI CMV period of the subsequent study
day (Figure 1). We conducted all daily, pre-HFO-TGI,
physiological, CMV measurements with CMV FiO2 set at
1.0 for ≥15 minutes.
Data collection and statistical analysis
On each study day, we obtained physiological measure-
ments over 5-minute periods at the previously mentioned
five times (Figure 1). For each 5-minute period, continu-
ously monitored variables were recorded once per minute
and then averaged. Standard formula-derived variables
included shunt fraction, peripheral O2 delivery rate, CPP,
respiratory compliance, and oxygenation index (Additional
file 1). Daily physiological data sets from each patient were
pooled and analyzed.
We conducted a compromise power analysis (G*Power
version 3.1; Duesseldorf University, Duesseldorf, Germany),
For a small effect size f of 0.10, a beta-to-alpha ratio of 4:1,
a total of 40 daily data sets (that is, observations), five levels
of the within-subjects factor (that is, ventilatory technique),
and a nonsphericity correction of 0.3 [17], the analysis
yielded an alpha value of 0.044, and a power of 0.83. We
estimated that each patient would require three or more
HFO-TGI sessions [19], each corresponding to one study-
data set [17]. Consequently, a minimum of 13 patients
would be required for study completion.
Data were analyzed by using SPSS Statistics version 20
(SPSS Inc., Chicago, IL, USA) and reported as mean ±
standard deviation (SD). Distribution normality was tested
by using the Kolmogorov-Smirnov test. Physiological vari-
able data obtained at the reported measurement time
points were compared with repeated measures analysis of
variance for one within-subjects factor. The Bonferroni
correction was used for pairwise post hoc comparisons.
Pre-HFO-TGI and post-HFO-TGI CMV plateau pressure
and respiratory-compliance data were compared with a
paired t test. Significance was set at P < 0.05.
Results
During the study period, we administered rescue HFO-
TGI sessions to 13 eligible TBI/ARDS patients. Table 1
displays baseline data of the patients, their Marshall score
[25] on hospital admission and their neurologic outcome.
On enrolment, six patients had ICP >20 mm Hg and/or
CPP <60 mm Hg; average, total TIL score was 17.3 ± 5.1
(range, 11 to 28; Additional file 1, Table S1 [23]). Nine
and four patients required a total of three and four daily
HFO-TGI sessions (respectively), according to our prespe-
cified oxygenation criteria. No need was seen for extension
or interruption of any HFO-TGI session, and none of the
HFO-TGI sessions was cancelled. In 13 (30.2%) of 43
HFO-TGI sessions, RMs were cancelled (n = 11) or
aborted (n = 2) (see Additional file 1, Table S2).
Secondary insults, such as ICP >20 mm Hg, and CPP
<60 mm Hg with/without concurrent hypotension, were
recorded in 23 (53.5%) of 43 study days corresponding to
nine (69.2%) of 13 patients. Insults were effectively treated
with further increases in TIL. In all of these cases, at least
one insult occurred during CMV. Insults during HFO-TGI
were recorded in 19 (44.2%) of 43 study days and in seven
(53.8%) of 13 patients (full relevant data reported in Addi-
tional file 1, Table S2). This is consistent with the subse-
quently reported improvements in ICP and CPP control
observed during HFO-TGI. In three (7.0%) of 43 study
days, concurrent increases in post-HFO-TGI PaCO2 (of
>5 mm Hg) and ICP (to 23 to 26 mm Hg) were treated
mainly by increasing CMV minute ventilation by 1 to
2 L/min (Additional file 1, Supplement to Results and
Table S2).
We did not observe any of the potential HFO and/or
TGI-associated complications [16-19], apart from transi-
ent hypotension within the first 2 minutes of HFO-TGI
initiation. This protocol-related complication occurred
just after the 20-second first RM in nine (20.9%) of
43 HFO-TGI sessions, corresponding to six (46.2%) of
13 patients. In all cases, the pre-HFO-TGI hemodynamic
status was restored within 15 minutes after a temporary
increase in vasopressor infusion and a fluid bolus (see
Methods and Additional file 1, Supplement to Results and
Figure S1).
Ventilatory parameters and results on physiological
variables
We used CMV tidal volume, respiratory rate, minute ven-
tilation, and PEEP of 8.3 ± 1.3 ml/kg predicted body
weight, 26.6 ± 5.0 breaths/min, 15.0 ± 2.9 L/min, and 14.6
± 2.6 cm H2O, respectively. Table 2 displays the HFO-TGI
settings (along with CMV mPaw; see also Figure 1), results
on oxygenation index, and CMV respiratory mechanics.
HFO-TGI resulted in significant improvements in plateau
pressure and respiratory compliance (P < 0.01).
Results on PaO2/FiO2, PaCO2, pH, and cerebral hemo-
dynamics are shown in Figure 2. PaO2/FiO2 was higher
during HFO-TGI sessions versus pre-/post-HFO-TGI
CMV (P < 0.01). Furthermore, PaO2/FiO2 remained higher
during post-HFO-TGI CMV versus pre-HFO-TGI CMV
(P < 0.01). Accordingly, HFO-TGI was associated with sig-
nificant improvements in oxygenation index (Table 2),
shunt fraction, central-venous O2 saturation, and periph-
eral O2 delivery (Table 3). Furthermore, PaCO2 and pH
were improved after 4 hours of HFO-TGI relative to pre/
post HFO-TGI CMV, and after 8 hours of HFO-TGI rela-
tive to post-HFO-TGI CMV (Figure 2). ICP and CPP were
also improved after 4 hours of HFO-TGI relative to pre/
post HFO-TGI CMV (Figure 2). Last, besides the RM-
associated hypotension, HFO-TGI did not affect systemic
hemodynamics (Table 3).
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Table 1 Patient baseline characteristics, ventilatory settings on study enrollment, and outcome
Age (years) 33.1 ± 11.7
Sex (male/female) 9/4
Body mass index (kg/m2) 25.0 ± 1.8
PBW (kg)a 68.6 ± 8.3
TBI etiology
Road traffic accident, no/total no (%) 12/13 (92.3)
Fall from height >5 meters, no/total no (%) 1/13 (7.7)
Time from TBI (days)b 7.1 ± 1.8
Marshall classification of brain CT findings on hospital admission
Grade III: Diffuse injury and swelling, no./total no (%) 7/13 (53.9)
Grade VI: Nonevacuated mass lesion >25 ml, no/total no (%)c, d 6/13 (46.2)
Simplified Acute Physiology Score IIe 48.2 ± 11.9
Thiopental infusion, no/total no (%)f, g 4/13 (30.1)
PaO2/inspired O2 fraction (mm Hg)
f 85.9 ± 12.2
Fractional inspired O2
f 0.84 ± 0.14
PaCO2 (mm Hg)
f 42.4 ± 15.5
Arterial pHf 7.39 ± 0.10
Positive end-expiratory pressure (cm H2O)
f 13.9 ± 2.9
Tidal volume (ml/kg PBW)f 8.6 ± 1.8
Respiratory rate (breaths/min)f 25.8 ± 6.5
Minute ventilation (L/min)f 14.5 ± 2.9
Inspiratory-to-expiratory time ratiof 1:2
End-inspiratory plateau airway pressure (cm H2O)
f 33.5 ± 4.7
Mean airway pressure (cm H2O)
f 21.1 ± 2.9
Oxygenation indexf, h 25.3 ± 3.2
Quasistatic respiratory compliance (ml/cm H2O)
f, i 31.5 ± 6.1
Murray scoref 3.4 ± 0.4
Time from ARDS diagnosis (hours)k 34.9 ± 15.1
Pulmonary ARDS, no/total no (%)l 13/13 (100.0)
Outcome according to GOSE
Upper good recovery (GOSE = 8), no/total no (%)m 5/13 (38.5)
Lower good recovery (GOSE = 7), no/total no (%)m 2/13 (15.4)
Death (GOSE = 1), no/total no (%)n 6/13 (46.2)
Values are mean ± SD unless otherwise specified. TBI, traumatic brain injury; CT, computed tomography; PBW, predicted body weight; ARDS, acute respiratory
distress syndrome; GOSE, Glasgow Outcome Scale Extended.
aFor males, PBW was calculated as 50 + (height (cm) - 152.4) × 0.91; for females, 45.5 + (height(cm) - 152.4) × 0.91.
bRefers to the time interval between TBI and study enrollment.
cTwo patients with epidural hematoma and two patients with subdural hematoma were treated with neurosurgical evacuation within the first 3 hours after
hospital admission; on follow-up CT, three patients had diffuse injury III, and one patient (also subjected to decompressive craniectomy) had diffuse injury IV
findings.
dTwo patients with intracerebral hemorrhage received a ventriculostomy; on follow-up CT, one patient had diffuse injury III, and one patient had diffuse injury II
findings.
eDetermined within 12 hours before study enrolment.
fRecorded/determined within 10 minutes after study enrolment.
gIn all four patients, a thiopental infusion of 6 mg/kg/h was started within 24 hours before study enrolment, because their intracranial pressure exceeded 30 mm
Hg, despite the preceding combined use of propofol/midazolam anesthesia, hyperosmolar therapy, and increased minute ventilation.
hCalculated as mean airway pressure divided by the PaO2/inspired O2 fraction, and then multiplied by 100.
iCalculated as tidal volume divided by the difference between the end-inspiratory and end-expiratory plateau airway pressures.
kRefers to the time interval between establishment of ARDS diagnosis and study enrolment.
lEleven patients had severe, bilateral ventilator-associated pneumonia caused by Klebsiella pneumoniae (n = 5), or Acinetobacter baumannii (n = 4), or
Pseudomonas aeruginosa (n = 2). Four patients had bilateral pulmonary contusions, and one of them also had a new, unilateral area of consolidation with air-
bronchogram, also attributed to ventilator-associated pneumonia with Acinetobacter baumannii. One patient also received a massive blood transfusion within the
first 48 hours after hospital admission.
mDetermined at approximately 3 months after hospital discharge; data originate from patient follow-up records of the University-affiliated Department of
Neurosurgery of Evaggelismos Hospital.
nCorresponds to death in the intensive care unit within 6 to 16 days after study enrolment (see also Table S2 in Additional file 1).
Vrettou et al. Critical Care 2013, 17:R136
http://ccforum.com/content/17/4/R136
Page 5 of 10
Discussion
Our results support the use of HFO-TGI as rescue ventil-
atory strategy in patients with severe TBI and imminent
oxygenation failure due to severe ARDS. In TBI, even
a mild arterial hypoxemia (for example, PaO2 = 55 to
58 mm Hg) can cause cerebral vasodilation and exacerba-
tion of intracranial hypertension [5,26]. The linear relation
between PaCO2 and cerebral blood flow and volume [27]
mandates control of PaCO2 as well.
Current and prior [16-19] results indicate that HFO-TGI
substantially improves oxygenation versus CMV. Relative
to both CMV and standard HFO, HFO-TGI augments
lung base recruitment [16,18]. The high-velocity TGI jet
stream likely enhances HFO-dependent gas-transport
mechanisms, such as the asymmetry in inspiratory velocity
profiles, radial gas mixing, and molecular diffusion [16,17].
TGI also augments dead-space clearance and HFO tidal
volume and alveolar ventilation, thereby improving CO2
elimination [16,18].
During our current HFO-TGI technique, we used a tra-
cheal tube cuff leak, a high bias flow, and frequency and
ΔP settings that correspond to an HFO tidal volume of
180 to 200 ml (Figure 1; Table 2[28]). The latter constitu-
tes a 65% to 67% reduction of the pre-HFO-TGI CMV
tidal volume and is consistent with improved lung protec-
tion [10]. A better lung protection during post-HFO-TGI
CMV relative to pre-HFO-TGI CMV is also suggested by
our favorable results on post-HFO-TGI respiratory
mechanics (Table 2; [19]).
Assuming a stable chest-wall elastance (Ecw) during the
daily time intervals of the study protocol (Figure 1), the
observed increase in respiratory compliance (that is,
decrease in respiratory elastance) should reflect a decrease
in lung elastance (EL) due to HFO-TGI-associated recruit-
ment [16-19]. Also, intrapleural pressure (Ppl) is given by
the equation
Ppl = airway pressure × Ecw
/
(EL + Ecw)
This means that for the same airway pressure level and
Ecw, a decrease in EL is associated with an increase in Ppl.
Furthermore, in the present study, the average ventilator-
displayed HFO mPaw during HFO-TGI exceeded the
preceding average CMV mPaw by about 11 cm H2O
(Table 2). Consequently, Ppl was probably increased dur-
ing HFO-TGI compared with CMV.
An increase in Ppl could impede systemic and jugular
venous return, decrease cardiac output/index and mean
arterial pressure, increase ICP, and decrease CPP [30].
In contrast, we observed an initial improvement in cere-
bral hemodynamics during HFO-TGI (Figure 2). Possible
explanatory factors include (a) the mPaw decrease along
the tracheal tube during HFO-TGI, which results in a
mean tracheal pressure that is 5 to 6 cm H2O lower than
the ventilator-displayed HFO mPaw [16,19]; this means
that the present study’s actual, HFO-TGI-induced increase
in average mean tracheal pressure was probably within 5
to 7 cm H2O [16]; and (b) an HFO-TGI-induced lung
recruitment without concurrent hyperinflation [18]; this is
consistent with our favorable results on oxygenation/shunt
fraction, and PaCO2 (Figure 2 and Table 3).
A prior study of TBI/ARDS [31], showed that ICP and
CPP remain stable when an increase in ventilation pres-
sures (through PEEP increase from 0 to 10 cm H2O)
augments lung recruitment, without affecting PaCO2.
Alternative, rescue ventilatory strategies for severe
TBI/ARDS patients include prone positioning [5], high-
frequency percussive ventilation (HFPV) [5], CMV-TGI
[32], pumpless extracorporeal lung assist (pECLA) with
a heparin-coated circuit [5,33], and extracorporeal mem-
brane oxygenation (ECMO) [34]. Regarding the use of
the first two strategies in TBI/ARDS, only scarce and
inconclusive published data exist [5]. CMV-TGI may
allow less-traumatic CMV settings while maintaining
PaCO2 control [32]. CMV-TGI has the limitations of
TGI [35], without the option of cuff leak use to lower
expiratory airway resistance. pECLA and ECMO may
result in better gas exchange and lung protection, with
Table 2 Ventilatory parameters of HFO-TGI sessions, oxygenation index, and respiratory mechanics.
Ventilatory technique mPaw (cm H2O) Frequency
(Hz)







Pre HFO-TGI CMV 20.5 ± 3.1 NA NA NA 26.0 ± 8.5 30.4 ± 4.5 37.8 ± 9.2
HFO-TGI (4 hours) 31.6 ± 3.9 3.5 ± 0.4 80.9 ± 7.3 3.5 ± 0.4 20.6 ± 10.5* NA NA
HFO-TGI (8 hours) 30.9 ± 4.3 3.6 ± 0.6 80.4 ± 8.5 3.6 ± 0.8 17.5 ± 7.8* NA NA
HFO-TGI (12 hours) 30.2 ± 5.0 3.7 ± 0.9 80.1 ± 8.6 3.7 ± 0.9 15.3 ± 5.9*,§ NA NA
Post HFO-TGI CMV 19.5 ± 3.0 NA NA NA 15.3 ± 5.9*,§ 28.2 ± 4.6* 45.3 ± 13.1*
Values are mean ± SD. CMV, conventional mechanical ventilation; HFO, high-frequency oscillation; TGI tracheal gas insufflation; pre-HFO-TGI CMV, corresponds to
either the baseline CMV period of study day 1 or the 60-minute period that followed the 11-hour period of post-HFO-TGI CMV of the preceding study day (see
also Figure 1 and corresponding legend); mPaw, mean airway pressure, ΔP, oscillatory pressure amplitude; Pplateau, end-inspiratory plateau airway pressure; Cst,
static respiratory system compliance; NA, not applicable.
*P < 0.01 versus pre-HFO-TGI CMV.
§ P < 0.01 versus HFO-TGI at 4 hours.
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minimal concurrent risk of anticoagulation-induced side
effects [5,33,34].
Methodologic considerations
While designing the study, we anticipated that in severe
TBI patients, any new, ARDS-associated hypoxemia and/
or hypercapnia could cause reversible ICP perturbations
to values >20 mm Hg [5,22]. Furthermore, we considered
that an ICP level of 30 mm Hg constitutes an upper limit
for its eventual and effective control to ≤20 mm Hg
through increases in TIL [36]. Thus, we chose this
particular upper ICP limit for both study enrolment and
completion of our HFO-TGI intervention. Accordingly,
regarding RMs, we chose an upper limit of ICP = 25 mm
Hg, because we expected that any potential ICP increase
associated with a 20-second RM would most likely be ≤5
mm Hg, thus resulting in a maximal ICP of ≤30 mm Hg
during post-RM HFO-TGI [19]. This prediction is con-
sistent with the results of a prior study, which also used
ICP >25 mm Hg as the RM-abort criterion [35].
During pressure-controlled CMV, a 60-second RM
with an incremental peak pressure of up to 60 cm H2O
Figure 2 Results on gas-exchange and cerebral hemodynamics. CMV, conventional mechanical ventilation; HFO, high-frequency oscillation;
TGI, tracheal gas insufflation; pre-HFO-TGI CMV corresponds to either the baseline CMV period of study day 1, or the 60-minute period that
followed the 11-hour period of post-HFO-TGI CMV of the preceding study day (see also Figure 1 and corresponding legend). Left: results on
PaO2/fractional inspired oxygen (FiO2) (top diagram), PaCO2 (middle diagram), and arterial pH (bottom diagram) obtained, during CMV1 (that is,
just before HFO-TGI initiation), HFO-TGI at 4, 8, and 12 hours, and CMV2 (that is, at 30 minutes after HFO-TGI discontinuation; see also Figure 1
and corresponding legend). Right: results on intracranial pressure (top diagram) and cerebral perfusion pressure (bottom diagram) also obtained
at the previously mentioned time points. Squares and error bars represent mean and SD, respectively. *P < 0.01 versus pre-HFO-TGI CMV. †P <
0.01 versus post-HFO-TGI CMV. §P < 0.05 versus pre-HFO-TGI CMV and post-HFO-TGI CMV. ‡P < 0.05 versus pre-HFO-TGI CMV.
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(pressure level sustained for 30 seconds) may decrease
mean arterial pressure by about 15% and increase ICP
by about ~23%, with concurrent reductions of about
17% in CPP [35]. We applied a continuous positive air-
way pressure of 40 to 45 cm H2O for just 20 seconds.
In nine HFO-TGI sessions, the first RMs were asso-
ciated with average decreases of about 35% and about
44% in mean arterial pressure and CPP (respectively)
versus. pre-HFO-TGI CMV; furthermore, within 1 to 2
minutes after RM, the ICP increased by about 19% ver-
sus pre-HFO-TGI CMV (see Additional file 1, Figure
S1). These protocol-related, secondary insults were
promptly reversed by a temporary increase in vasopres-
sor support and volume loading. Insults did not recur
after subsequent RMs within the same HFO-TGI ses-
sion, and occurred independent of session order (Addi-
tional file 1, Supplement to Results, and Figure S1).
Volume-status optimization may have prevented transi-
ent hypotension after the second and third RM of the
HFO-TGI sessions [37].
Study limitations
Limitations of long-term TGI include the impact of the
high-velocity jet stream and/or an oscillating TGI cathe-
ter on the tracheal wall, causing mucosal necrosis and/
or hemorrhage [16-19,38,39], the inspissation of secre-
tions with the potential for partial or complete airway
obstruction in case of inadequate humidification of TGI
gas [16-19,38,40], and dynamic pulmonary hyperinfla-
tion, hemodynamic compromise, and pneumothorax
caused by the forward-thrust TGI that can impede
expiration [16-19,38]. Other potential complications
include venous gas embolism, interference of a TGI
catheter passed through the tracheal tube with suction-
ing [38], TGI catheter obstruction by secretions [19],
and absence of commercially available equipment speci-
fically designed for TGI administration [16-19,38]. In
our clinical practice, we intermittently superimpose
humidified TGI gas to HFO, and most frequently, for
≤12 hours [19]. Furthermore, during HFO-TGI, we use
a tracheal tube cuff leak, to increase the effective width
of the expiratory pathway, and thus reduce the risk of
hyperinflation and promote CO2 elimination [8,16-19].
In the present study, the use of brain-tissue O2 moni-
toring could have clarified the relation between the
HFO-TGI-induced improvement in arterial oxygenation
and the oxygenation of the brain tissue. It would have
also have been of great interest to include transcranial
Doppler ultrasonography measurements as part of the
trial, to investigate the effect of HFO-TGI on cerebral
blood flow. Finally, the study was noncontrolled and
nonrandomized. However, it provides the first support-
ing data on the feasibility, efficacy, and safety of HFO-
TGI in severe TBI/ARDS.
Conclusions
HFO-TGI improves oxygenation and lung mechanics
and does not adversely affect hemodynamics, CO2 elimi-
nation, ICP, and CPP when used to ventilate TBI
patients with severe ARDS. RMs can cause hemody-
namic complications and may have to be cancelled or
aborted.
Key messages
• The use of HFO in patients with TBI is limited
because of hypercapnia that occurs commonly
Table 3 Shunt fraction, peripheral perfusion indices, and hemodynamics
Ventilatory strategy Shunt fraction ScvO2 (%) Heart rate (beats/min) MAP (mm Hg)
Pre HFO-TGI CMV 0.49 ± 0.09 70.1 ± 6.2 95 ± 24 92 ± 12
HFO-TGI (4 hours) 0.31 ± 0.09* 74.0 ± 3.9 *,§ 92 ± 23 94 ± 13
HFO-TGI (8 hours) 0.29 ± 0.06* 74.6 ± 4.1 *,§ 92 ± 23 93 ± 14
HFO-TGI (12 hours) 0.29 ± 0.06* 75.0 ± 4.1 *,§ 92 ± 22 90 ± 15
Post HFO-TGI CMV 0.33 ± 0.14 70.5 ± 6.2 92 ± 22 90 ± 14
Ventilatory strategy Cardiac Index (L/min/m2 BSA) DO2 Index
(ml/min/m2 BSA)
Arterial blood lactate (mM) CVP (mm Hg)
Pre HFO-TGI CMV 4.8 ± 1.3 510 ± 119 1.72 ± 0.70 12 ± 3.4
HFO-TGI (4 hours) 4.7 ± 1.1 541 ± 119 § 1.82 ± 0.68 12 ± 3.0
HFO-TGI (8 hours) 4.8 ± 1.1 553 ± 114 *,§ 1.85 ± 0.68 12 ± 2.9
HFO-TGI (12 hours) 4.7 ± 1.2 551 ± 119 *,§ 1.82 ± 0.69 12 ± 2.8
Post HFO-TGI CMV 4.5 ± 1.1 513 ± 106 1.81 ± 0.74 11.5 ± 3.3
Values are mean ± SD. CMV, conventional mechanical ventilation; HFO, high-frequency oscillation; TGI, tracheal gas insufflation; pre-HFO-TGI CMV, corresponds to
either the baseline CMV period of study day 1, or the 60-minute period that followed the 11-hour period of post-HFO-TGI CMV of the preceding study day (see
also Figure 1 and corresponding legend); ScvO2, central venous O2 saturation; MAP, mean arterial pressure; BSA, body surface area; DO2, peripheral O2 delivery;
CVP, central venous pressure.
* P < 0.01 versus pre-HFO-TGI CMV
§ P < 0.05 versus post-HFO-TGI CMV
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during HFO, even at relatively low HFO frequencies
of about5 Hz. Hypercapnia can have deleterious
effects on ICP and CPP.
• The addition of TGI to HFO improves oxygenation
and enhances CO2 elimination, thereby providing a
theoretically suitable lung-protective strategy for
patients with ARDS/TBI.
• In this work, we showed that rescue sessions of
HFO-TGI administered to TBI patients with severe
ARDS result in improved gas exchange, higher post-
HFO-TGI respiratory compliance, and less-traumatic
CMV pressures, without adversely affecting ICP and/
or CPP.
• Our findings support the design of randomized
controlled trials to evaluate the use of HFO-TGI in
patients with ARDS and TBI.
Additional material
Additional file 1: Electronic Supplementary Material to High-
Frequency Oscillation and tracheal gas insufflation in patients with
severe acute respiratory distress syndrome and traumatic brain
injury: An interventional physiological study. Details of methods and
data not shown in the main manuscript.
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